[
    [
        {
            "time": "",
            "original_text": "年营收400亿！增速秒杀恒瑞、石药！这货业绩如此彪悍，什么东西？",
            "features": {
                "keywords": [
                    "营收",
                    "增速",
                    "恒瑞",
                    "石药",
                    "业绩"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "年营收400亿！增速秒杀恒瑞、石药！这货业绩如此彪悍，什么东西？",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 10,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "科创板生物医药公司系列研究之复旦张江:自主产权核心技术管线丰富,拳头品种持续放量",
            "features": {
                "keywords": [
                    "科创板",
                    "生物医药",
                    "复旦张江",
                    "核心技术",
                    "管线",
                    "拳头品种"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "科创板生物医药公司系列研究之复旦张江:自主产权核心技术管线丰富,拳头品种持续放量",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-03-20",
            "original_text": "收盘突破年线个股一览",
            "features": {
                "keywords": [
                    "收盘",
                    "突破",
                    "年线"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "收盘突破年线个股一览",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "上海医药：持有复旦张江22.77%股份",
            "features": {
                "keywords": [
                    "上海医药",
                    "复旦张江",
                    "股份"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海医药：持有复旦张江22.77%股份",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药周观点:业绩浪、长期资金持续流入,医药蓝筹白马股价历史新高再新高",
            "features": {
                "keywords": [
                    "医药",
                    "业绩浪",
                    "长期资金",
                    "蓝筹",
                    "白马股",
                    "股价新高"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药周观点:业绩浪、长期资金持续流入,医药蓝筹白马股价历史新高再新高",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]